SEC Form 4 · accession 0001179110-15-010601
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Naseem Amin
Director
Period of report
Jun 29, 2015
Accepted (ET)
Jul 1, 2015 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.78 | Jun 29, 2015 | A | 25,000 | A | — | Jun 28, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1This option was granted on June 29, 2015. This option vests in three equal annual installments over a three-year period from the date of grant.